Lansoprazol Pentafarma Especialidades

Lansoprazole, the active ingredient in Lansoprazol Pentafarma Especialidades, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is indicated for the treatment of gastro‑oesophageal reflux disease, peptic ulcer disease, Helicobacter pylori eradication regimens and Zollinger‑Ellison syndrome in adult patients.

GNH USA supplies Lansoprazol Pentafarma Especialidades as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole acts on the gastric proton pump to lower acid secretion, making it useful for several acid‑related conditions. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and esophagitis by reducing gastric acid exposure. - Peptic ulcer disease: promotes ulcer healing and prevents recurrence by maintaining a less acidic gastric environment. - Helicobacter pylori eradication regimens: used in combination therapy to increase eradication rates. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors.

Common Side Effects: - Headache: mild to moderate pain often transient. - Diarrhea: loose stools that may resolve with continued therapy. - Abdominal pain: discomfort or cramping in the stomach area. - Nausea: feeling of unease or urge to vomit. - Flatulence: increased intestinal gas. - Constipation: difficulty passing stools.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis, Stevens‑Johnson syndrome): require immediate medical attention. - Clostridioides difficile infection: may cause severe colitis. - Elevated liver enzymes: indicate possible hepatic injury. - Hypomagnesemia: low magnesium levels with prolonged use. - Interstitial nephritis: inflammation of kidney tissue. - Acute pancreatitis: inflammation of the pancreas.

Before initiating therapy, consider the following precautions: - Assess renal function: adjust use in severe renal impairment. - Monitor for infection: prolonged acid suppression can increase risk of C. difficile. - Check magnesium levels: long‑term treatment may cause hypomagnesemia. - Avoid abrupt discontinuation: may lead to rebound acid hypersecretion. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Lansoprazole may interact with several medications, requiring careful management. Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption and efficacy. - High‑dose methotrexate: increased toxicity. - Warfarin: enhanced anticoagulant effect. - Digoxin: increased serum concentrations.

Moderate Interactions (Monitor Closely): - Cyclosporine: increased blood levels. - Phenytoin: reduced anticonvulsant efficacy. - Ketoconazole: decreased absorption. - Iron supplements: reduced iron absorption. - Vitamin B12: possible deficiency with long‑term use.